Clinical Research Directory
Browse clinical research sites, groups, and studies.
From the Emergency Department Directly to Ablation of Atrial Fibrillation Study
Sponsor: Asklepios proresearch
Summary
The study is a prospective, two-arm, randomized, open-label, blinded endpoint, multi-center study to investigate the impact of first line ablation in patients presenting at the emergency room with recent-onset paroxysmal or persistent atrial fibrillation.
Official title: From the Emergency Department Directly to Ablation of Atrial Fibrillation - Study - The "EMERGE-Cryo-Study"
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
350
Start Date
2021-12-15
Completion Date
2028-12-14
Last Updated
2025-04-10
Healthy Volunteers
No
Conditions
Interventions
Ablation of atrial fibrillation (AF)
Cryo-AF-ablation of pulmonary vein (pulmonary vein isolation = PVI)
Locations (13)
Asklepios Klinik St. Georg
Hamburg, Hamburg, Germany
Universitäres Herz- und Gefäßzentrum
Hamburg, Hamburg, Germany
Kerckhoff-Klinik GmbH
Bad Nauheim, Germany
Deutsches Herzzentrum der Charité
Berlin, Germany
Herzzentrum Uniklinik Köln
Cologne, Germany
Evangelisches Krankenhaus Düsseldorf
Düsseldorf, Germany
Cardioangiologisches Zentrum Bethanien (CCB) am Markuskrankenhaus
Frankfurt, Germany
Universitätsklinikum Giessen
Giessen, Germany
AK Altona
Hamburg, Germany
AK Nord
Hamburg-Nord, Germany
Asklepios Klinik Harburg
Harburg, Germany
Universitätsklinikum Münster
Münster, Germany
St. Josefs-Hospital Wiesbaden GmbH
Wiesbaden, Germany